Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Carbomer Copolymer Type B

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ANDRODERM

    02 1AVAGE

    03 2BIAXIN

    04 1BIAXIN XL

    05 1CLOBETASOL PROPIONATE

    06 1CLOBEX

    07 1IMPEKLO

    08 1NIZORAL ANTI-DANDRUFF

    09 1SOOLANTRA

    10 1TAZAROTENE

    11 1TAZORAC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    TESTOSTERONE

    Drug : ANDRODERM

    Dosage Form : FILM, EXTENDED RELEASE; TRANSDERMAL

    Application Number : 20489

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLARITHROMYCIN

    Drug : BIAXIN

    Dosage Form : TABLET; ORAL

    Application Number : 50662

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLARITHROMYCIN

    Drug : BIAXIN

    Dosage Form : FOR SUSPENSION; ORAL

    Application Number : 50698

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ABBVIE
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLARITHROMYCIN

    Drug : BIAXIN XL

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Application Number : 50775

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ALLERGAN
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    TAZAROTENE

    Drug : AVAGE

    Dosage Form : CREAM; TOPICAL

    Application Number : 21184

    Country : US

    Patented : No

    Abbvie CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    ALLERGAN
    U.S.A
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    TAZAROTENE

    Drug : TAZORAC

    Dosage Form : CREAM; TOPICAL

    Application Number : 21184

    Country : US

    Patented : No

    Abbvie CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    GALDERMA LABS LP

    Clobetasol Propionate

    ELCC
    Not Confirmed
    arrow

    08

    GALDERMA LABS LP

    Ivermectin

    ELCC
    Not Confirmed
    arrow

    09

    KRAMER

    Ketoconazole

    ELCC
    Not Confirmed
    arrow

    10

    NORVIUM BIOSCIENCE

    Clobetasol Propionate

    ELCC
    Not Confirmed
    arrow
    NORVIUM BIOSCIENCE
    arrow
    ELCC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLOBETASOL PROPIONATE

    Drug : IMPEKLO

    Dosage Form : LOTION; TOPICAL

    Application Number : 213691

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF